Evaluation of the balance between angiogenic and antiangiogenic circulating factors in patients with breast and gastrointestinal cancers

Clinical Cancer Research

Volumn 4, Issue 5, 1998, Pages 1221-1225

  Morelli, Daniele ^a   Lazzerini, Debora ^a   Cazzaniga, Sara ^a   Squicciarini, Paolo ^a   Bignami, Paola ^a   Maier, Jeanette A M ^b   Sfondrini, Lucia ^a   Ménard, Sylvie ^a   Colnaghi, Maria I ^a   Balsari, Andrea ^a,c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; THROMBOSPONDIN; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BREAST CANCER; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION;

BREAST NEOPLASMS; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTORS; GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPHOKINES; MALE; NEOPLASM PROTEINS; THROMBOSPONDIN 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 15644374164     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
2. Perez-Atayde, A. R., Sallan, S. E., Tedrow, U., Connors, S., Allred, E., and Folkman, J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am. J. Pathol., 150: 815-821, 1997.
3. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
4. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., and Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 143: 401-409, 1993.
5. Li, V. W., Folkerth, R. D., Watanabe, H., Yu, C., Rupnick, M., Barnes, T., Scott, R. M., Black, P. M., Sallan, S. E., and Folkman, J. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with tumors. Lancet, 344: 82-86, 1994.
6. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
7. Horak, E. R., Leek, R., Klenk, N., LeJeune, S., Smith, K., Stuart, N., Greenall, M., Stepniewska, K., and Harris, A. L. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastases and survival in breast cancer. Lancet, 340: 1120-1124, 1992.
8. Hanahan, D., and Folkman, J. Patterns and emerging mechanism of the angiogenic switch during tumorigenesis. Cell. 86: 353-364, 1996.
9. Good, D. J., Polverini, P. J., Rastinejad, F., LeBeau, M. M., Lemons, R. S., Frazier, W. A., and Bouck, N. P. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA, 87: 6624-6628, 1990.
10. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin. A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
11. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin. An endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
12. Takei, Y., Kurobe, M., Uchida, A., and Hayashi, K. Serum concentrations of basic fibroblast growth factor in breast cancer. Clin. Chem., 40: 1980-1981, 1994.
13. Chakrabarty, S., Huang, S., Moskal, T. L., and Fritsche, H. A., Jr. Elevated serum levels of transforming growth factor α in breast cancer patients. Clin. Cancer Res., 1: 1031-1034, 1995.
14. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.
15. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-32, 1995.
16. Folkman, J. What is the role of thymidine phosphorylase in tumor angiogenesis? J. Natl. Cancer Inst., 88: 1091-1092, 1996.
17. Yamamoto, Y., Toi, M., Kondo, S., Matsumoto, T., Suzuki, H., Kitamura, M., Tsuruta, K., Taniguchi, T., Okamoto, A., Mori, T., Yoshida, M., Ikeda, T., and Tominaga, T. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin. Cancer Res., 2: 821-826, 1996.
18. Schnaper, H. W., McGowan, K. A., Kim-Schulze, S., and Cid, M. C. Oestrogen and endothelial cell angiogenic activity. Clin. Exp. Pharmacol. Physiol., 23: 247-250, 1996.
19. Iruela-Arispe, M. L., Porter, P., Bornstein, P., and Sage, E. H. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J. Clin. Invest., 97: 403-412, 1996.